Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm disorders such as atrial fibrillation (AFib) Pulsed field ablation – or ...
On Monday, the U.S. Food and Drug Administration (FDA) approved Abbott Laboratories’ (NYSE: ABT) Volt PFA System to treat patients battling atrial fibrillation (AFib). AFib is the most common type of ...
On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA System to treat patients with atrial fibrillation, or AFib. The company ...
Atrial fibrillation (AFib) is a heart condition that can affect even the fittest individuals, often presenting without obvious symptoms. As a dedicated cyclist in good health, I was surprised by my ...
With winter and the holiday season well underway, so is cold weather, warm drinks and plenty of frenzying, which together can be dangerous, or even fatal, to some with heart conditions. Between 1979 ...
ABBOTT PARK, Ill. - Abbott (NYSE:ABT), the $218 billion healthcare equipment giant with revenue of $43.8 billion over the last twelve months, announced Monday that the U.S. Food and Drug ...
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...
Bristol Myers Squibb (NYSE: BMY, “BMS”) today announced an agreement with the U.S. government to provide Eliquis® (apixaban), an oral anticoagulant relied upon by millions of Americans daily, for free ...
Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Courtesy of Abbott Labs On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback